Sign in

CIK 0001622229

  • Large accelerated filer

Cogent Biosciences, Inc.

Sign in to watch
Ticker
COGT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
465308248
Phone
+1 617-945-5576
Business address
180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
Former names
Unum Therapeutics Inc., Unum Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,689,493
in 1 filing, $1.7M under 10b5-1 plans

Net −$1,689,493. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Morris Arlene −$1.7M Director sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2018-04-03 FMR LLC Conversion · Series A Preferred Stock −35,614 0
2018-04-03 FMR LLC Conversion · Series B Preferred Stock −13,505 0
2018-04-03 FMR LLC Conversion · Series B Preferred Stock −73,065 0
2018-04-03 FMR LLC Conversion · Series B Preferred Stock −877 0
2018-04-03 Ratcliffe Liam Director Conversion +622,772 622,772
2018-04-03 Ratcliffe Liam Director Conversion +622,773 622,773
2018-04-03 Ratcliffe Liam Director Purchase +275,000 $12.00 $3.3M 897,772
2018-04-03 Ratcliffe Liam Director Purchase +275,000 $12.00 $3.3M 897,773
2018-04-03 Ratcliffe Liam Director Conversion · Series B Preferred Stock −977,835 0
2018-04-03 Ratcliffe Liam Director Conversion · Series B Preferred Stock −977,836 0
2018-04-03 Atlas Venture Fund IX, L.P. 10% owner Conversion +3,184,446 3,184,446
2018-04-03 Atlas Venture Fund IX, L.P. 10% owner Conversion +83,037 3,267,483
2018-04-03 Atlas Venture Fund IX, L.P. 10% owner Purchase +94,052 $12.00 $1.1M 3,361,535
2018-04-03 Atlas Venture Fund IX, L.P. 10% owner Conversion · Series A Preferred Stock −3,184,446 0
2018-04-03 Atlas Venture Fund IX, L.P. 10% owner Conversion · Series B Preferred Stock −83,037 0
2018-04-03 Booth Bruce Director Conversion +3,184,446 3,184,446
2018-04-03 Booth Bruce Director Conversion +83,037 3,267,483
2018-04-03 Booth Bruce Director Purchase +94,052 $12.00 $1.1M 3,361,535
2018-04-03 Booth Bruce Director Conversion · Series A Preferred Stock −3,184,446 0
2018-04-03 Booth Bruce Director Conversion · Series B Preferred Stock −83,037 0

Page 16 of 16 · 320 trades